Ultragenyx PharmaceuticalRARE
13F holders, Q1 2026 (March 31)298holders +10
55new positions
47sold out
7famous investors
$20.93avg. 13F price*
At the end of Q1 2026, 298 institutions reported holding Ultragenyx Pharmaceutical Inc. (RARE) in their 13F filings, up 10 from Q4 2025. 55 opened new positions and 47 sold out. The largest holders were BlackRock, Inc. ($152.9M), Vanguard Portfolio Management LLC ($112.8M) and State Street Corp. ($105.2M). 7 famous investors held it, including Cliff Asness (0.0% of AQR Capital Management's portfolio), Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ultragenyx Pharmaceutical Inc.
- CUSIP
- 90400D108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 55 | $110.3M |
| Exits | 47 | $176.2M |
All 13F filers, Q4 2025 → Q1 2026: 30,120,770 shares bought and 25,291,086 shares sold, net +4,829,684 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 298 holders
| BlackRock, Inc. | 0.00% | Add +10.1% | 7,299,598 | $152.9M |
| Vanguard Portfolio Management LLC | 0.01% | — | 5,385,992 | $112.8M |
| State Street Corp. | 0.00% | Add +16.7% | 5,021,441 | $105.2M |
| AQR Capital Management | 0.04% | Add +236.5% | 4,578,024 | $95.9M |
| Vanguard Capital Management LLC | 0.00% | — | 4,189,831 | $87.8M |
| RTW Investments, LP | 0.76% | Add +21.6% | 3,648,795 | $76.4M |
| Sands Capital Management, LLC | 0.26% | Reduce -7.8% | 3,214,533 | $67.3M |
| Sofinnova Investments, Inc. | 3.30% | Add +3676.6% | 3,145,888 | $65.9M |
| Wellington Management Group LLP | 0.01% | Add +7.3% | 2,640,812 | $55.3M |
| Bellevue Group AG | 1.19% | Add +92148.1% | 2,380,000 | $49.9M |
| Assenagon Asset Management S.A. | 0.08% | Add +1030.4% | 2,257,671 | $47.3M |
| Two Sigma Investments, LP | 0.04% | Add +420.2% | 2,205,820 | $46.2M |
| Frontier Capital Management Co. LLC | 0.47% | Add +11.5% | 2,191,182 | $45.9M |
| Citadel Advisors | 0.03% | Reduce -9.1% | 2,115,491 | $44.3M |
| Geode Capital Management, LLC | 0.00% | Add +0.6% | 1,849,391 | $38.8M |
| Millennium Management | 0.03% | Add +101.2% | 1,772,184 | $37.1M |
| GW&K Investment Management, LLC | 0.30% | Add +17.4% | 1,615,426 | $33.8M |
| Morgan Stanley | 0.00% | Reduce -17.8% | 1,500,528 | $31.4M |
| Jacobs Levy Equity Management, Inc. | 0.13% | Reduce -18.2% | 1,431,071 | $30.0M |
| Voloridge Investment Management, LLC | 0.12% | Add +121.8% | 1,426,834 | $29.9M |
| D. E. Shaw & Co. | 0.02% | Add +265.8% | 1,261,018 | $26.4M |
| Rock Springs Capital Management LP | 1.50% | Reduce -3.8% | 1,218,773 | $25.5M |
| Jones Hill Capital LP | 5.23% | — | 1,165,557 | $24.4M |
| Candriam S.C.A. | 0.12% | Add +37.1% | 1,096,182 | $23.0M |
| Bank of America Corp. | 0.00% | Reduce -13.8% | 1,046,546 | $21.9M |
| Qube Research & Technologies Ltd | 0.03% | New | 914,760 | $19.2M |
| Point72 Asset Management | 0.03% | New | 893,295 | $18.7M |
| Eagle Health Investments LP | 3.89% | New | 884,121 | $18.5M |
| Catalio Capital Management, LP | 3.72% | Add +423.4% | 850,797 | $17.8M |
| UBS Group AG | 0.00% | Add +24.5% | 832,740 | $17.4M |
| Sphera Funds Management LTD. | 2.92% | Add +169.2% | 809,333 | $17.0M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -48.3% | 804,109 | $16.8M |
| Nuveen, LLC | 0.00% | Reduce -17.4% | 662,054 | $13.9M |
| HRT Financial LP | 0.03% | Add +22.2% | 613,229 | $12.8M |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 608,219 | $12.7M |
| Palo Alto Investors LP | 1.91% | Add +29.3% | 596,495 | $12.5M |
| Legal & General Group Plc | 0.00% | Add +43.5% | 590,294 | $12.4M |
| Renaissance Technologies | 0.02% | Add +53.4% | 561,700 | $11.8M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -6.8% | 558,486 | $11.7M |
| Pictet Asset Management Holding SA | 0.01% | Reduce -51.0% | 603,571 | $11.7M |
| Northern Trust Corp. | 0.00% | Add +1.7% | 535,566 | $11.2M |
| Susquehanna International Group, LLP | 0.01% | Add +244.6% | 524,798 | $11.0M |
| Jump Financial, LLC | 0.17% | Add +334.9% | 504,143 | $10.6M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.02% | Add +89.8% | 500,922 | $10.5M |
| Schonfeld Strategic Advisors LLC | 0.08% | Reduce -33.3% | 494,737 | $10.4M |
| BNP Paribas Financial Markets | 0.01% | Reduce -45.6% | 490,783 | $10.3M |
| Ikarian Capital, LLC | 1.45% | Add +3708.5% | 482,571 | $10.1M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | Add +71.4% | 480,000 | $10.1M |
| Manufacturers Life Insurance Company, The | 0.01% | Add +36.2% | 451,119 | $9.5M |
| Squarepoint Ops LLC | 0.02% | Add +13.8% | 444,539 | $9.3M |
| Algert Global LLC | 0.14% | Add +95.5% | 428,529 | $9.0M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Reduce -78.0% | 418,149 | $8.8M |
| Russell Investments Group, Ltd. | 0.01% | Reduce -52.1% | 402,959 | $8.4M |
| Newtyn Management, LLC | 0.90% | Add +35.2% | 400,000 | $8.4M |
| Krensavage Asset Management, LLC | 3.20% | Add +161.2% | 390,879 | $8.2M |
| Trexquant Investment LP | 0.06% | Add +136.0% | 389,467 | $8.2M |
| Balyasny Asset Management L.P. | 0.02% | Reduce -26.1% | 384,364 | $8.1M |
| Privium Fund Management B.V. | 1.59% | Add +2.0% | 364,802 | $7.6M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -11.8% | 353,097 | $7.4M |
| SummitTX Capital, L.P. | 0.23% | New | 347,760 | $7.3M |
| Bank of New York Mellon Corp | 0.00% | Add +14.2% | 341,125 | $7.1M |
| Citigroup Inc. | 0.00% | Add +353.8% | 315,440 | $6.6M |
| Franklin Resources Inc. | 0.00% | Add +1.1% | 312,628 | $6.5M |
| Blue Owl Capital Holdings LP | 1.71% | Add +42.3% | 302,638 | $6.3M |
| Fred Alger Management, LLC | 0.03% | Reduce -27.6% | 298,032 | $6.2M |
| Invesco Ltd. | 0.00% | Add +25.8% | 289,572 | $6.1M |
| GordonMD Global Investments LP | 4.22% | Reduce -12.2% | 289,101 | $6.1M |
| FMR LLC | 0.00% | Reduce -89.2% | 287,316 | $6.0M |
| Massachusetts Financial Services Co. | 0.00% | Reduce -16.0% | 260,385 | $5.5M |
| Barclays PLC | 0.00% | Reduce -30.4% | 249,807 | $5.2M |
| Parkman Healthcare Partners LLC | 0.51% | Add +278.9% | 235,000 | $4.9M |
| Longaeva Partners L.P. | 0.23% | New | 228,107 | $4.8M |
| JPMorgan Chase & Co. | 0.00% | Reduce -93.8% | 245,928 | $4.7M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +9.3% | 223,048 | $4.7M |
| Motley Fool Wealth Management, LLC | 0.53% | Reduce -25.0% | 222,981 | $4.7M |
| Kennedy Capital Management LLC | 0.10% | New | 219,291 | $4.6M |
| Y-Intercept (Hong Kong) Ltd | 0.09% | New | 218,354 | $4.6M |
| Brevan Howard Capital Management LP | 0.05% | Add +100.0% | 215,845 | $4.5M |
| Man Group plc | 0.01% | Add +172.2% | 213,352 | $4.5M |
| Quantinno Capital Management LP | 0.01% | Add +276.9% | 187,508 | $3.9M |
| Nomura Asset Management International Inc. | 0.01% | Reduce -0.6% | 181,773 | $3.8M |
| Ishara Investments LP | 3.69% | Add +248.5% | 174,250 | $3.7M |
| Jane Street Group, LLC | 0.00% | Reduce -83.0% | 173,743 | $3.6M |
| Woodline Partners LP | 0.01% | No change | 171,805 | $3.6M |
| Swiss National Bank | 0.00% | No change | 171,052 | $3.6M |
| Rafferty Asset Management, LLC | 0.01% | Add +5.3% | 165,431 | $3.5M |
| Schroder Investment Management Group | 0.00% | Add +2.0% | 179,097 | $3.5M |
| Marshall Wace, LLP | 0.00% | Add +118.3% | 157,526 | $3.3M |
| Moore Capital Management, LP | 0.13% | Reduce -21.4% | 157,132 | $3.3M |
| Worldquant Millennium Advisors LLC | 0.01% | Add +55.4% | 150,587 | $3.2M |
| Boothbay Fund Management, LLC | 0.07% | New | 141,978 | $3.0M |
| Group One Trading LLC | 0.10% | Add +504.0% | 140,166 | $2.9M |
| SR One Capital Management, LP | 0.32% | No change | 137,753 | $2.9M |
| Corient Private Wealth LP | 0.00% | New | 136,544 | $2.9M |
| B Group, Inc. | 2.10% | No change | 135,000 | $2.8M |
| Capital Fund Management S.A. | 0.02% | Reduce -19.2% | 121,374 | $2.5M |
| Walleye Capital LLC | 0.02% | Add +228.1% | 119,705 | $2.5M |
| Fifth Third Bancorp | 0.00% | New | 110,272 | $2.3M |
| Caption Management, LLC | 0.11% | Reduce -49.9% | 110,000 | $2.3M |
| Entropy Technologies, LP | 0.11% | Add +81.0% | 109,727 | $2.3M |
"% of holder's portfolio" is RARE's weight in each manager's 13F, not the share of Ultragenyx Pharmaceutical Inc. the manager owns.